Go to deals
Healthcare

Empirical Bioscience has been acquired by Fortis Life Sciences

The owner of Empirical Bioscience has sold the company to Fortis Life Sciences.

Empirical Bioscience is a leading developer and manufacturer of enzymes, proteins and reagents for molecular biology and life science applications. Empirical focuses on supplying premium, quality and custom-configured products to the life sciences industry for both research and commercial applications. The company has a comprehensive library of products that can be readily configured to customer specifications and offers technical support to assist with the development and launch of assays and products.

Fortis Life Sciences is a strategic platform providing capital, expertise and operational resources enabling the growth and success of founder-led life science tools companies.

One of Oaklins’ teams in the USA served as the financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences.

Service
M&A sell-side
Parties

Talk to the deal team

 Bradford A. Adams

Bradford A. Adams

Managing Director
Boston, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital
 Harrison P. Boeschenstein

Harrison P. Boeschenstein

Analyst
Boston, United States
Oaklins TM Capital

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Laboratoire Dazont has been acquired by SBM Company
Healthcare

Laboratoire Dazont has been acquired by SBM Company

The shareholders of Laboratoire Dazont have sold the company to SBM Company.

Learn more
Monument MicroCap Partners has sold Montgomery DME to Incline Equity Partners
Private Equity | Healthcare

Monument MicroCap Partners has sold Montgomery DME to Incline Equity Partners

Monument MicroCap Partners, LLC (MMP) has sold Montgomery DME (MDME) to Incline Equity Partners.

Learn more